GERGEN MARK J (President and CBO) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/3/2025ACC: 0000950170-25-001527
DirectorOfficer· President and CBO
Since Jul 2020
-23.31K
Net shares
Net seller
$223.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
23.31K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.31K
Price / share
$9.60
Trade value
$223.80K
% of position
3.6%
1/2/2025
654.04K→630.73K
Total
Net shares
−23.31K
Net value
-$223.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | F · Tax Withholding | −23.31K | $9.60 | $223.80K | 3.6% | 654.04K | 630.73K |
| Total | −23.31K | -$223.80K | ||||||
Derivative Transactions0
No derivative transactions reported